Biliary tract cancer

Novel Prognostic Model for Postoperative Cholangiocarcinoma Patients

Researchers from Naval Medical University, Shanghai, People's Republic of China, have developed a novel prognostic model to predict the outcomes of postoperative patients with stage I intrahepatic cholangiocarcinoma (ICC). According to the study, surgery is commonly recommended for stage I ICC patients, but the independent prognostic factors affecting

New Insights into Cholangiocarcinoma Personalized Medicine

Researchers at Kagawa University in Japan have made a significant breakthrough in understanding the genetic and molecular alterations of cholangiocarcinoma (CCA), a type of cancer that affects the bile ducts. The study, published in the journal Cancers, sheds light on the impact of underlying etiologic factors, such as hepatitis B